4.5 Article

Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic Studies

期刊

EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
卷 2021, 期 20, 页码 1921-1928

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ejic.202100120

关键词

Alkynyl ligands; Cytotoxicity; Gold; Thioredoxin reductase; Translocator proteins

资金

  1. European Union's Horizon 2020 research and innovation programme (H2020-MSCA-IF-2016) [REP-749621-1]
  2. National Cancer Institute [P30 CA071789]
  3. IReL
  4. B.H. and Alice C. Beams Endowed Professorship in Cancer Research

向作者/读者索取更多资源

A series of gold(I) complexes were synthesized and characterized, with two of them showing cytotoxic effects in bladder cancer cells by inducing reactive oxygen species and caspase-mediated apoptosis. These complexes also inhibit thioredoxin reductase, a known target of anticancer gold(I) complexes, suggesting a potential mechanism of action for their anticancer effects.
A series of gold(I) complexes with the general formula [Au(L2)(L ')] (L2=4-phenyl-N-(prop-2-yn-1-yl)quinazoline-2-carboxamide, L '=PPh3 (triphenylphosphine), 1; TPA (1,3,5-triaza-7-phosphaadamantane), 2, and Me-2-imy (1,3-dimethylimidazol-2-ylidene), 3) were synthesized and fully characterized by spectroscopic methods. The alkynyl ligand L2 belongs to the quinazoline carboxamide class of ligands that are known to bind to the translocator protein (TSPO) at the outer mitochondrial membrane. 1 and 2 exert cytotoxic effects in bladder cancer cells with IC50 values in the low micromolar range. Further mechanistic analysis indicated that the two complexes both act by inducing reactive oxygen species and caspase-mediated apoptosis. The complexes inhibit thioredoxin reductase, an established target of anticancer gold(I) complexes. Docking studies confirmed that after ligand exchange the free ligand L2 can interact with the TSPO binding site.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据